After decades of work, an effective cytomegalovirus vaccine is on the horizon
Read now →Monoclonal antibodies reveal key vaccine structure
Georgina To'a Salazar
Chemical Engineering and Biomedical Engineering
University of Texas Health Science Center at Houston
Since 2015 I have been at at the University of Texas Health Science Center at Houston in a group developing and characterizing therapeutic antibodies targeting cancer and infectious diseases. I have a BS in Chemical Engineering from Stanford and a PhD in Biomedical Engineering from the UC Irvine. As a postdoc, I fulfilled a dream of living and working outside the US. I conducted tissue engineering research at the National University of Singapore. Then, I spent two years as an assistant professor in a regenerative medicine group at the University of Tsukuba in Japan. Returning to the US, I expanded my work in science communication, pursuing a long-term goal of work in science policy. My dream job would be working to facilitate international research collaborations to address issues where cooperation benefits us all, such as infectious diseases and redesigning energy production to protect human health and environments.
Monoclonal antibodies reveal key vaccine structure
The virus can lead to severe complications in children and organ transplant recipients
Their results suggest the human virome may one day help treat certain cancers